KIAA1530 activators comprise a category of chemical agents that are engineered to enhance the activity of KIAA1530, a protein encoded by the UVSSA gene. This protein plays a significant role in transcription-coupled nucleotide excision repair (TC-NER), a DNA damage repair pathway that is crucial for maintaining genomic stability. The precise mechanisms by which KIAA1530 contributes to TC-NER are complex and involve interaction with other proteins and DNA itself. Activators of KIAA1530 are designed to either increase the protein's stability, promote its interaction with its partners in the TC-NER pathway, or augment its ability to bind to DNA. By doing so, these molecules can potentiate the normal functional role of KIAA1530 within the cellular framework. The design of these activators requires in-depth knowledge of the protein's structure and the molecular dynamics of its interactions within the nucleus of the cell.
The development process for KIAA1530 activators typically involves an extensive exploration of the protein's structure-function relationship, often using advanced molecular biology techniques to identify key domains and interactions that are essential for its operation within TC-NER. This foundational knowledge facilitates the use of high-throughput screening methods to identify initial candidate molecules that possess the potential to interact with KIAA1530 in a beneficial manner. These candidate activators may then be subjected to a series of refinement and optimization processes, leveraging techniques such as computational modeling, medicinal chemistry, and iterative synthesis to enhance their potency, selectivity, and cellular uptake.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin forms DNA adducts and crosslinks, leading to DNA damage. This can upregulate DNA repair mechanisms, potentially increasing the expression or activity of KIAA1530 as part of the cellular response to maintain genomic integrity. | ||||||
Methyl methanesulfonate | 66-27-3 | sc-250376 sc-250376A | 5 g 25 g | $56.00 $133.00 | 2 | |
MMS alkylates DNA, which can lead to the recruitment and activation of various DNA repair proteins. KIAA1530, being part of the nucleotide excision repair pathway, may have increased activity as part of the cellular response to MMS-induced DNA damage. | ||||||
VE 821 | 1232410-49-9 | sc-475878 | 10 mg | $360.00 | ||
VE-821 inhibits the ATR kinase, a key regulator of the DNA damage response. While inhibition typically reduces pathway activity, the cellular compensation mechanisms might increase the recruitment of alternative repair proteins like KIAA1530 to maintain DNA integrity. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-FU is metabolized into metabolites that incorporate into DNA and RNA, disrupting their normal function and causing damage, which can stimulate the DNA damage response and possibly the activity of KIAA1530 in an effort to repair affected DNA. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C crosslinks DNA, triggering a cellular response to DNA damage that may include the activation of KIAA1530 as part of the nucleotide excision repair process. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA, obstructing transcription and replication processes. This can activate DNA damage response pathways, potentially increasing the activity of DNA repair proteins, including KIAA1530. | ||||||